Publications scientifiques sur les diagnostics non invasifs BioPredictive

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.

Bonnard P et al. · J Viral Hepat · 2015 Score 100

In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to…

FibroTest HCV

Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.

El-Shabrawi MH et al. · Eur J Gastroenterol Hepatol · 2010 Score 97

### Background Hepatitis C virus (HCV) is a major cause of chronic hepatitis…

ActiTest FibroTest HCV

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Fouad A et al. · Int J Gen Med · 2013 Score 94

### Background Steatosis is common in patients with hepatitis C virus (HCV) infection…

HCV

Retracted: Executive functions in chronic hepatitis C virus infected elderly patients.

· Geriatr Gerontol Int · 2015 Score 90

FibroTest HCV

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.

Elalfy MS et al. · Ann Hepatol · 2013 Score 87

### Background The main causes of liver fibrosis in transfusion-dependent thalassemia major…

ActiTest FibroTest HCV

Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

· 2014 Score 84

These are the first guidelines dealing with hepatitis C treatment produced by…

FibroTest HCV

Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C.

Awad Mel-D et al. · J Egypt Soc Parasitol · 2013 Score 80

The study evaluated liver stiffness measurement (LSM) using non-invasive transient elastography…

ActiTest FibroTest HCV

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Key publication

Shiha G et al. · Hepatol Int · 2009 Score 77

Liver fibrosis is a common pathway leading to cirrhosis, which is the…

FibroTest SteatoTest HBV HCV +1

Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.

Chou R et al. · Ann Intern Med · 2013 Score 74

### Background Many blood tests have been proposed as alternatives to liver biopsy…

FibroTest HCV

Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.

Yakoob R et al. · Ann Gastroenterol · 2015 Score 70

### Background The aim of this study was to compare noninvasive biomarkers, FibroTest…

ActiTest FibroTest HCV

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

Myers RP et al. · Am J Gastroenterol · 2002 Score 67

### Objectives Liver fibrosis in chronic hepatitis C is related to sex, age…

FibroTest HCV

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.

Poynard T et al. · JHEP Rep · 2021 Score 64

### Background & Aims The Liver Cancer Risk test algorithm (LCR1-LCR2) is a…

LCR1 LCR2 HCV

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

European Association for the Study of the Liver · J Hepatol · 2011 Score 60

ActiTest FibroTest HCV

Ministère des Affaires Sociales et de la Santé Key publication

Score 57

FibroTest HBV HCV

Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection

· 2015 Score 54

These are the first World Health Organization (WHO) guidelines for the prevention…

FibroTest HBV